Cargando…
Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and e...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742381/ https://www.ncbi.nlm.nih.gov/pubmed/36504430 http://dx.doi.org/10.1002/ctm2.1068 |
_version_ | 1784848503477895168 |
---|---|
author | Burkard, Tobias Herrero San Juan, Martina Dreis, Caroline Kiprina, Anastasiia Namgaladze, Dmitry Siebenbrodt, Kai Luger, Sebastian Foerch, Christian Pfeilschifter, Josef M. Weigert, Andreas Radeke, Heinfried H. |
author_facet | Burkard, Tobias Herrero San Juan, Martina Dreis, Caroline Kiprina, Anastasiia Namgaladze, Dmitry Siebenbrodt, Kai Luger, Sebastian Foerch, Christian Pfeilschifter, Josef M. Weigert, Andreas Radeke, Heinfried H. |
author_sort | Burkard, Tobias |
collection | PubMed |
description | BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and effector function to the harsh and nutrient‐deprived conditions of the disease‐associated microenvironment. METHODS: We used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8(Low) versus CD8(High) T cells and performed FACS‐Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8(Low) versus the CD8(High) T cells were then used to investigate the presence of these cell subsets in immune‐related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8(+) T cell subsets in cancer and relapsing‐remitting multiple sclerosis patients. RESULTS: Starvation induced a decreased expression of CD8, yielding a CD8(Low) T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8(Low) T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8(High) T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8(High) T cells in close proximity to tumour cells, while the CD8(Low) T cells resided at the tumour boundaries. Importantly, the number of tumour‐infiltrating CD8(Low) T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8(Low) T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. CONCLUSIONS: In summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis. |
format | Online Article Text |
id | pubmed-9742381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97423812022-12-13 Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis Burkard, Tobias Herrero San Juan, Martina Dreis, Caroline Kiprina, Anastasiia Namgaladze, Dmitry Siebenbrodt, Kai Luger, Sebastian Foerch, Christian Pfeilschifter, Josef M. Weigert, Andreas Radeke, Heinfried H. Clin Transl Med Research Articles BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and effector function to the harsh and nutrient‐deprived conditions of the disease‐associated microenvironment. METHODS: We used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8(Low) versus CD8(High) T cells and performed FACS‐Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8(Low) versus the CD8(High) T cells were then used to investigate the presence of these cell subsets in immune‐related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8(+) T cell subsets in cancer and relapsing‐remitting multiple sclerosis patients. RESULTS: Starvation induced a decreased expression of CD8, yielding a CD8(Low) T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8(Low) T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8(High) T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8(High) T cells in close proximity to tumour cells, while the CD8(Low) T cells resided at the tumour boundaries. Importantly, the number of tumour‐infiltrating CD8(Low) T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8(Low) T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. CONCLUSIONS: In summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis. John Wiley and Sons Inc. 2022-12-11 /pmc/articles/PMC9742381/ /pubmed/36504430 http://dx.doi.org/10.1002/ctm2.1068 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Burkard, Tobias Herrero San Juan, Martina Dreis, Caroline Kiprina, Anastasiia Namgaladze, Dmitry Siebenbrodt, Kai Luger, Sebastian Foerch, Christian Pfeilschifter, Josef M. Weigert, Andreas Radeke, Heinfried H. Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title | Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title_full | Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title_fullStr | Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title_full_unstemmed | Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title_short | Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis |
title_sort | differential expression of cd8 defines phenotypically distinct cytotoxic t cells in cancer and multiple sclerosis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742381/ https://www.ncbi.nlm.nih.gov/pubmed/36504430 http://dx.doi.org/10.1002/ctm2.1068 |
work_keys_str_mv | AT burkardtobias differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT herrerosanjuanmartina differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT dreiscaroline differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT kiprinaanastasiia differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT namgaladzedmitry differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT siebenbrodtkai differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT lugersebastian differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT foerchchristian differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT pfeilschifterjosefm differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT weigertandreas differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis AT radekeheinfriedh differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis |